Novo Nordisk A-S

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$77.82-$147.59
Market Cap
$349.9B
Shares Short
13M

Financials

See more
Revenue (12 Mos)
$290.4B
Revenue Growth (YoY)
30.1%
Gross Profit (12 Mos)
$246.8B
Diluted EPS
$3.15

News

See more

Yahoo Finance • 2 days ago

NVO STOCK NEWS: NVO Shareholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Novo Nordisk A/S

Yahoo Finance • 2 days ago

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVO

Yahoo Finance • 2 days ago

Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial’s Design – Hagens Berman

Yahoo Finance • 3 days ago

Shareholders of Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights – NVO

About

CEO
Mr. Lars Fruergaard Jorgensen
CFO
Mr. Karsten Munk Knudsen
Address
Novo Alle 1, Bagsvaerd, Denmark, 2880
Sector
Healthcare
Industry
Drug Manufacturers - General
Full-Time Employees
71,880